Rosemary A Crane insider trades: Teva Pharmaceutical Industries (TEVA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rosemary reports to the SEC
and 2 more companies
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 11, 2020 | TEVA | ↓ Sell | 2,860 | $11.90 | $34K | Direct | Aug 13, 2020 (2d) |
| Feb 5, 2014 | MELA | ↑ Buy | 67,570 | $0.74 | $50K | Direct | Feb 6, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TEVA insiders
Open-market trades in the last 12 months
About Rosemary A Crane's insider trades
Rosemary A Crane is an insider at Teva Pharmaceutical Industries (TEVA). Since Feb 5, 2014, Rosemary has reported 1 open-market purchase worth $50K and 1 sale worth $34K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (29 filings), option exercises (18 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TEVA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.